01758oam 2200505 450 991071180380332120210503105827.0(CKB)5470000002488049(OCoLC)1086389949(EXLCZ)99547000000248804920190220d2019 ua 0engurgn|||||||||txtrdacontentcrdamediacrrdacarrierExamining implementation of the Compounding Quality Act hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018Washington :U.S. Government Publishing Office,2019.1 online resource (vi, 286 pages) illustrations"Serial no. 115-96."Includes bibliographical references.Examining implementation of the Compounding Quality Act DrugsDosage formsGovernment policyUnited StatesPharmaceutical industryGovernment policyUnited StatesDrug adulterationUnited StatesPreventionLegislative hearings.lcgftDrugsDosage formsGovernment policyPharmaceutical industryGovernment policyDrug adulterationPrevention.GPOGPOMERUCTEUOCLCONKFOCLCFOCLCOTXROCLCOCOOGPOBOOK9910711803803321Examining implementation of the Compounding Quality Act3544452UNINA